EVEKEO ODT - Pulmonology Advisor


Indications for: EVEKEO ODT

Attention deficit hyperactivity disorder.

Adult Dosage:

Use other forms.

Children Dosage:

<6yrs: not established. Individualize. Take in the AM. 6–17yrs: initially 5mg once or twice daily; give additional dose after 4–6hrs if needed. Titrate in increments of 5mg at weekly intervals; usual max 40mg/day. Switching from Evekeo tabs: give on a mg-per-mg basis. Switching from other amphetamine products: see full labeling.

EVEKEO ODT Contraindications:

During or within 14 days of MAOIs.

Boxed Warning:

Abuse and dependence.

EVEKEO ODT Warnings/Precautions:

Abuse potential (monitor). Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors in developing manic episode prior to initiating. Consider discontinuing if new psychotic/manic symptoms occur. Monitor for seizures, serotonin syndrome; discontinue if occurs. Peripheral vasculopathy, including Raynaud's phenomenon; monitor for digital changes. Monitor BP, HR, growth in children. Write ℞ for smallest practical amount. Reevaluate periodically. Pregnancy; monitor for neonatal withdrawal symptoms. Nursing mothers: not recommended.

EVEKEO ODT Classification:

CNS stimulant.

EVEKEO ODT Interactions:


Adverse Reactions:

Decreased appetite, insomnia, abdominal pain, affect lability, injury; hypertension, tachycardia.



Generic Drug Availability:


How Supplied:

Blister card 5mg, 10mg, 15mg—30; 20mg—15, 30